HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamide

structure in first source
Also Known As:
ML012; VU 0255035; VU-0255035; VU0255035
Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Conn, P Jeffrey: 2 articles (03/2012 - 08/2009)
2. Jones, Carrie K: 2 articles (03/2012 - 08/2009)
3. Lindsley, Craig W: 2 articles (03/2012 - 08/2009)
4. Xiang, Zixiu: 2 articles (03/2012 - 08/2009)
5. Ciruela, Francisco: 1 article (01/2020)
6. Crans, René A J: 1 article (01/2020)
7. Fernández-Dueñas, Víctor: 1 article (01/2020)
8. Massari, Caio M: 1 article (01/2020)
9. Stove, Christophe P: 1 article (01/2020)
10. Taura, Jaume: 1 article (01/2020)

Related Diseases

1. Catalepsy
2. Mitochondrial Diseases (Mitochondrial Disease)
3. Status Epilepticus (Complex Partial Status Epilepticus)
4. Seizures (Absence Seizure)

Related Drugs and Biologics

1. Muscarinic M1 Receptor
2. Scopolamine (Hyoscine)
3. Reserpine (Serpasil)
4. Pirenzepine
5. Pilocarpine (Ocusert)
6. Organophosphates
7. Haloperidol (Haldol)
8. muscarinic toxin 7
9. U 95666E